https://orcid.org/0000-0001-7213-5631
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qiuhua Fan. (2022) A Clinical Nursing Care Study on the Prevalence of Rotavirus Infection and Acute Diarrhea in Vaccinated Chinese Pediatric Population from 2019–2022. Infection and Drug Resistance 15, pages 6129-6142.
Read now
Read now
Frédéric Debellut, Clint Pecenka, William P. Hausdorff & Andrew Clark. (2022) Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Articles from other publishers (21)
Asma Sadiq & Jadoon Khan. (2024) Rotavirus in developing countries: molecular diversity, epidemiological insights, and strategies for effective vaccination. Frontiers in Microbiology 14.
Crossref
Crossref
Arnold W. Lambisia, Nickson Murunga, Martin Mutunga, Robinson Cheruiyot, Grace Maina, Timothy O. Makori, D. James Nokes & Charles N. Agoti. (2024) Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, during the COVID-19 pandemic, 2019–2022. Gut Pathogens 16:1.
Crossref
Crossref
Sandro Roier, Vidya Mangala Prasad, Monica M. McNeal, Kelly K. Lee, Benjamin Petsch & Susanne Rauch. (2023) mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents. npj Vaccines 8:1.
Crossref
Crossref
Edward Cunningham-Oakes, Christina Bronowski, End Chinyama, Khuzwayo C. Jere, Kulandaipalayam Natarajan C. Sindhu, Gagandeep Kang, Miren Iturriza-Gómara, Alistair C. Darby & Edward P. K. Parker. (2023) Increased bacterial taxonomic and functional diversity is associated with impaired rotavirus vaccine immunogenicity in infants from India and Malawi. BMC Microbiology 23:1.
Crossref
Crossref
Busara Charoenwat, Kunanya Suwannaying, Watuhatai Paibool, Napat Laoaroon, Sumitr Sutra, Kaewjai Thepsuthammarat & Suphasarang Sirirattanakul. (2023) The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis. BMC Public Health 23:1.
Crossref
Crossref
Asmaa El-Heneidy, Keith Grimwood, Stephen B Lambert & Robert S Ware. (2023) Interference Between Enteric Viruses and Live-Attenuated Rotavirus Vaccine Virus in a Healthy Australian Birth Cohort. The Journal of Infectious Diseases 228:7, pages 851-856.
Crossref
Crossref
Frank B Williams, Md Abdul Kader, Dorothy M Dickson, E Ross Colgate, Masud Alam, Rashidul Haque, William A PetriJrJr, Beth D Kirkpatrick & Benjamin Lee. (2023) Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea. Open Forum Infectious Diseases 10:6.
Crossref
Crossref
A Duncan Steele, George E Armah, Jason M Mwenda & Carl D Kirkwood. (2023) The Full Impact of Rotavirus Vaccines in Africa Has Yet to Be Realized. Clinical Infectious Diseases 76:Supplement_1, pages S1-S4.
Crossref
Crossref
Natasha Makabilo Laban, Samuel Bosomprah, Michelo Simuyandi, Mwelwa Chibuye, Adriace Chauwa, Masuzyo Chirwa-Chobe, Nsofwa Sukwa, Chikumbutso Chipeta, Rachel Velu, Katanekwa Njekwa, Cynthia Mubanga, Innocent Mwape, Martin Rhys Goodier & Roma Chilengi. (2023) Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial. Vaccines 11:2, pages 346.
Crossref
Crossref
Zhenlu Sun, Guifang Zhang, Chunyan Li, Peihua Niu, Xia Li, Qiao Gao, Kai Guo, Ruiqing Zhang, Ji Wang & Xuejun Ma. (2023) Rotavirus Infection and Genotyping in Yantai, Shandong Province, 2017–2019. Tropical Medicine and Infectious Disease 8:2, pages 101.
Crossref
Crossref
Pooja R. Kuri & Pranab Goswami. (2022) Current Update on Rotavirus in-Silico Multiepitope Vaccine Design. ACS Omega 8:1, pages 190-207.
Crossref
Crossref
Natalie I Mazur, Jonne Terstappen, Ranju Baral, Azucena Bardají, Philippe Beutels, Ursula J Buchholz, Cheryl Cohen, James E CroweJrJr, Clare L Cutland, Linda Eckert, Daniel Feikin, Tiffany Fitzpatrick, Youyi Fong, Barney S Graham, Terho Heikkinen, Deborah Higgins, Siddhivinayak Hirve, Keith P Klugman, Leyla Kragten-Tabatabaie, Philippe Lemey, Romina Libster, Yvette Löwensteyn, Asuncion Mejias, Flor M Munoz, Patrick K Munywoki, Lawrence Mwananyanda, Harish Nair, Marta C Nunes, Octavio Ramilo, Peter Richmond, Tracy J Ruckwardt, Charles Sande, Padmini Srikantiah, Naveen Thacker, Kody A Waldstein, Dan Weinberger, Joanne Wildenbeest, Dexter Wiseman, Heather J Zar, Maria Zambon & Louis Bont. (2023) Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet Infectious Diseases 23:1, pages e2-e21.
Crossref
Crossref
Frédéric Debellut, Kevin Tang, Andrew Clark, Clint Pecenka, Bachir Assao, Ousmane Guindo, Rebecca F Grais & Sheila Isanaka. (2022) Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines. BMJ Open 12:10, pages e061673.
Crossref
Crossref
Adam L Cohen, James A Platts-Mills, Tomoka Nakamura, Darwin J Operario, Sébastien Antoni, Jason M Mwenda, Goitom Weldegebriel, Gloria Rey-Benito, Lucia H de Oliveira, Claudia Ortiz, Danni S Daniels, Dovile Videbaek, Simarjit Singh, Emmanuel Njambe, Mohamed Sharifuzzaman, Varja Grabovac, Batmunkh Nyambat, Josephine Logronio, George Armah, Francis E Dennis, Mapaseka L Seheri, Nokululeko Magagula, Jeffrey Mphahlele, Tulio M Fumian, Irene T A Maciel, Jose Paulo Gagliardi Leite, Matthew D Esona, Michael D Bowen, Elena Samoilovich, Galina Semeiko, Dilip Abraham, Sidhartha Giri, Ira Praharaj, Gagandeep Kang, Sarah Thomas, Julie Bines, Na Liu, Hmwe H Kyu, Matthew Doxey, Elizabeth T Rogawski McQuade, Timothy L McMurry, Jie Liu, Eric R Houpt, Jacqueline E Tate, Umesh D Parashar & Fatima Serhan. (2022) Aetiology and incidence of diarrhoea requiring hospitalisation in children under 5 years of age in 28 low-income and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network. BMJ Global Health 7:9, pages e009548.
Crossref
Crossref
Cornelius A. Omatola & Ademola O. Olaniran. (2022) Rotaviruses: From Pathogenesis to Disease Control—A Critical Review. Viruses 14:5, pages 875.
Crossref
Crossref
Tintu Varghese, Gagandeep Kang & Andrew Duncan Steele. (2022) Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality. Vaccines 10:3, pages 346.
Crossref
Crossref
Natasha Makabilo Laban, Martin Rhys Goodier, Samuel Bosomprah, Michelo Simuyandi, Caroline Chisenga, Obvious Nchimunya Chilyabanyama & Roma Chilengi. (2022) T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review. Viruses 14:3, pages 459.
Crossref
Crossref
William P. Hausdorff, Jessica Price, Frédéric Debellut, Jessica Mooney, Andrew A. Torkelson, Khatuna Giorgadze & Clint Pecenka. (2022) Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines. Vaccines 10:2, pages 149.
Crossref
Crossref
Benjamin Lee, Md Abdul Kader, E. Ross Colgate, Marya Carmolli, Dorothy M. Dickson, Sean A. Diehl, Masud Alam, Sajia Afreen, Josyf C. Mychaleckyj, Uma Nayak, William A. PetriJr.Jr., Rashidul Haque & Beth D. Kirkpatrick. (2021) Oral rotavirus vaccine shedding as a marker of mucosal immunity. Scientific Reports 11:1.
Crossref
Crossref
Thabiso V. Miya, Michelle J. Groome & Debra de Assis Rosa. (2021) TLR genetic variation is associated with Rotavirus–specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine. Vaccine 39:48, pages 7028-7035.
Crossref
Crossref
Sarah Caddy, Guido Papa, Alexander Borodavka & Ulrich Desselberger. (2021) Rotavirus research: 2014–2020. Virus Research 304, pages 198499.
Crossref
Crossref